• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Rune Labs Launches AI and Personalized Coaching Care Management Service for Parkinson’s Disease

by Syed Hamza Sohail 03/06/2025 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

What You Should Know:

–  Rune Labs, the leader in precision medicine for Parkinson’s Disease (PD), today launched StrivePD Guardian, a personalized care service that combines expert coaching with AI-powered symptom and risk analysis to provide continuous support for people with Parkinson’s disease and their caregivers. 

–  With a shortage of movement disorder specialists in the U.S., many Parkinson’s individuals struggle to get the guidance they need between doctor visits. 

StrivePD Guardian: Transforming Parkinson’s Care with AI-Driven Insights and Personalized Support

Rune Labs, a software and data analytics company specializing in precision neurology, advances both care delivery and therapy development. Its flagship ecosystem, StrivePD, enables patients with Parkinson’s disease and their clinicians to optimize disease management through access to comprehensive objective and subjective data. This approach facilitates improved treatment decisions and connects patients to clinical trials. Biopharma and medical device companies leverage Rune Labs’ technology, clinician and patient network, and large longitudinal real-world datasets to expedite therapeutic development. The company is backed by leading investors, including Nexus NeuroTech, Eclipse Ventures, DigiTx, TruVenturo, and Moment Ventures.

StrivePD Guardian: AI-Driven Coaching and Health Monitoring
StrivePD Guardian bridges critical care gaps by integrating real-time personalized coaching, AI-powered health monitoring, and proactive insights. Built on Rune Labs’ industry-leading, value-based care framework validated in 2024, the program demonstrated significant outcomes: nearly a 50% reduction in emergency room visits, an 18% reduction in specialists’ time, a 90% increase in patient exercise engagement, and an 80% improvement in medication adherence.

Comprehensive Patient Support and Insights
StrivePD Guardian is a subscription-based service that combines human support with the latest Large Language Model (LLM) technology, utilizing patient data collected via StrivePD and FDA-cleared Apple Watch monitoring. It enhances yearly clinical visits by optimizing treatment strategies and enabling on-demand, data-informed care. Key features include:

·       1:1 Personalized Coaching: Users are paired with dedicated coaches who provide guidance, monitor progress, and support care management. Leveraging the StrivePD app and Apple Watch, coaches track FDA-cleared measures such as tremor and dyskinesia while adapting care to each patient’s unique disease journey.

·       Actionable Insights Based on Individual Data: AI-driven analysis translates patient data into meaningful insights, assisting clinicians and patients in making informed decisions about tailored exercise programs, therapies, symptom management, and clinical trial participation.

·       Proactive Risk Monitoring: Continuous health monitoring detects potential high-risk events, such as falls or complications, with timely alerts to prevent escalation.

·       Family and Caregiver Support: StrivePD Guardian connects families, ensuring they remain informed and reassured about their loved one’s care.

Impact on Patients’ Lives
StrivePD Guardian empowers patients by enhancing symptom stability and improving overall disease management. Users report increased control over their movements, greater consistency in exercise routines, and better adherence to medication regimens. By leveraging over 4.5 million patient-days of data, StrivePD’s predictive modeling and AI-driven insights continuously refine and personalize Parkinson’s care, supporting both patients and their healthcare providers in achieving better outcomes.

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |